Devices, systems and methods for evaluation of hemostasis
First Claim
Patent Images
1. An apparatus for evaluation of hemostasis, comprising:
- a housing that is configured to couple to a system, wherein the system comprises one or more transducers for each of a plurality of test chambers, wherein the system comprises at least one processor and memory having instructions stored thereon, wherein the instructions when executed by the at least one processor cause the at least one processor to direct the one or more transducers associated with each of the plurality of test chambers in the interrogation of the test sample to determine at least one viscoelastic property of the test sample;
the plurality of test chambers, including a first test chamber, a second test chamber, and a third test chamber, that are each at least partially defined by the housing; and
a fluid pathway having an inlet, defined by the housing, and from which an external vessel establishes fluid communication, to receive a test sample, wherein the fluid pathway is in fluid communication with the first test chamber, the second test chamber, and the third test chamber to deliver the test sample, or a portion thereof, to the first test chamber, the second test chamber, and the third test chamber,wherein each of the plurality of test chambers comprises a reagent or combination of reagents, and wherein each of the plurality of test chambers, including the first, second, and third test chambers, is configured to receive, via the fluid pathway, blood of a test sample to be interrogated to determine a plurality of hemostatic parameters;
wherein the first test chamber comprises a first reagent or a first combination of reagents that interact with the blood received therein, wherein the first reagent, or a reagent included in the first combination of reagents, is configured to activate coagulation via extrinsic or intrinsic pathway;
wherein the second test chamber comprises a second combination of reagents that interact with blood of the test sample received therein, wherein the second combination of reagents includes i) a reagent, or a combination of reagents, configured to activate coagulation via the extrinsic or intrinsic pathway and ii) a reagent, or a combination of reagents, configured to inhibit platelet contraction; and
wherein the third test chambers comprises a third reagent or a third combination of reagents that interact with the blood received therein, wherein the third reagent, or a reagent included in the third combination of reagents, is configured to activate coagulation via the extrinsic or intrinsic pathway.
1 Assignment
1 Petition
Accused Products
Abstract
Provided are devices, systems and methods for evaluation of hemostasis. Also provided are sound focusing assemblies.
186 Citations
63 Claims
-
1. An apparatus for evaluation of hemostasis, comprising:
-
a housing that is configured to couple to a system, wherein the system comprises one or more transducers for each of a plurality of test chambers, wherein the system comprises at least one processor and memory having instructions stored thereon, wherein the instructions when executed by the at least one processor cause the at least one processor to direct the one or more transducers associated with each of the plurality of test chambers in the interrogation of the test sample to determine at least one viscoelastic property of the test sample; the plurality of test chambers, including a first test chamber, a second test chamber, and a third test chamber, that are each at least partially defined by the housing; and a fluid pathway having an inlet, defined by the housing, and from which an external vessel establishes fluid communication, to receive a test sample, wherein the fluid pathway is in fluid communication with the first test chamber, the second test chamber, and the third test chamber to deliver the test sample, or a portion thereof, to the first test chamber, the second test chamber, and the third test chamber, wherein each of the plurality of test chambers comprises a reagent or combination of reagents, and wherein each of the plurality of test chambers, including the first, second, and third test chambers, is configured to receive, via the fluid pathway, blood of a test sample to be interrogated to determine a plurality of hemostatic parameters; wherein the first test chamber comprises a first reagent or a first combination of reagents that interact with the blood received therein, wherein the first reagent, or a reagent included in the first combination of reagents, is configured to activate coagulation via extrinsic or intrinsic pathway; wherein the second test chamber comprises a second combination of reagents that interact with blood of the test sample received therein, wherein the second combination of reagents includes i) a reagent, or a combination of reagents, configured to activate coagulation via the extrinsic or intrinsic pathway and ii) a reagent, or a combination of reagents, configured to inhibit platelet contraction; and wherein the third test chambers comprises a third reagent or a third combination of reagents that interact with the blood received therein, wherein the third reagent, or a reagent included in the third combination of reagents, is configured to activate coagulation via the extrinsic or intrinsic pathway. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19)
-
-
20. A system for evaluation of hemostasis comprising:
-
a plurality of test chambers, including a first test chamber and a second test chamber, wherein each of the plurality of test chambers comprises a reagent or combination of reagents, and wherein each of the plurality of test chambers is configured to receive blood of a test sample and to be interrogated to determine a hemostatic parameter of the blood received therein; one or more transducers for transmitting energy into one or more test chamber and for receiving reflected energy from the chamber and the sample therein; at least one processor in communication with the one or more transducers, wherein the processor is configured to determine the hemostatic parameters from signals transmitted to the processor from the one or more transducers; and a memory having instructions stored thereon, wherein the instructions when executed by the at least one processor, cause the at least one processor to perform at least three measurements in parallel; wherein the first test chamber comprises a first reagent or a first combination of reagents that interact with the blood of the test sample received therein, wherein the first reagent, or at least one reagent included in the first combination of reagents, is an activator of coagulation; and wherein the second test chamber comprises a second combination of reagents that interact with blood of the test sample received therein, the second combination of reagents including an activator of coagulation and a reagent, or a combination of reagents, configured to cause a reduction in measurable changes in clot mechanical properties of the test sample when the test sample is interrogated by the one or more transducers. - View Dependent Claims (21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41)
-
-
42. A system for evaluation of hemostasis comprising:
-
a plurality of test chambers, including a first test chamber and a second test chamber, wherein each of the plurality of test chambers comprises a reagent or a combination of reagents, and wherein each of the plurality of test chambers is configured to receive blood of a test sample and to be interrogated to determine a hemostatic parameter of the blood received therein; one or more transducers for transmitting energy into one or more test chamber and for receiving reflected energy from the chamber and the sample therein; at least one processor in communication with the one or more transducers, the processor being configured to determine the hemostatic parameters from signals transmitted to the processor from the one or more transducers; and a memory having instructions stored thereon, wherein execution of the instructions by the at least one processor cause the at least one processor to determine the hemostatic parameters in parallel; wherein the first chamber comprises a first reagent or a first combination of reagents that interact with the blood received therein, wherein the first reagent, or a reagent included in the first combination of reagents, is an activator of coagulation; and wherein the second chamber comprises a second combination of reagents that interact with blood of the test sample received therein, the second combination of reagents including an activator of coagulation and a reagent, or a combination of reagents, configured to inhibit platelet functions. - View Dependent Claims (43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60)
-
-
61. A system for evaluation of hemostasis comprising:
-
a plurality of test chambers, including a first test chamber and a second test chamber, wherein each of the plurality of test chambers comprises a reagent or combination of reagents, and wherein each of the plurality of test chambers is configured to receive blood of a test sample and to be interrogated to determine a hemostatic parameter of the blood received therein; one or more transducers for transmitting energy into one or more test chamber and for receiving reflected energy from the chamber and the sample therein; at least one processor in communication with the one or more transducers, wherein the processor is configured to determine the hemostatic parameters from signals transmitted to the processor from the one or more transducers; and a memory having instructions stored thereon, wherein the instructions when executed by the at least one processor, cause the at least one processor to determine a curve associated with a viscoelastic property of the blood of each test sample, the curve being generated from the interrogation as a function of time; wherein the first test chamber comprises a first reagent or a first combination of reagents that interact with the blood of the test sample received therein, wherein the first reagent, or at least one reagent included in the first combination of reagents, is an activator of coagulation; and wherein the second test chamber comprises a second combination of reagents that interact with blood of the test sample received therein, the second combination of reagents including an activator of coagulation and a reagent, or a combination of reagents, configured to cause a reduction in measurable changes in clot mechanical properties of the test sample when the test sample is interrogated by the one or more transducers. - View Dependent Claims (62, 63)
-
Specification